mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.09 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.09 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.09 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.09 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.09 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.09 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |